Takashi Watanabe

2.8k total citations
126 papers, 1.9k citations indexed

About

Takashi Watanabe is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Takashi Watanabe has authored 126 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 36 papers in Molecular Biology and 32 papers in Pathology and Forensic Medicine. Recurrent topics in Takashi Watanabe's work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CAR-T cell therapy research (11 papers). Takashi Watanabe is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CAR-T cell therapy research (11 papers). Takashi Watanabe collaborates with scholars based in Japan, United States and United Kingdom. Takashi Watanabe's co-authors include Kensei Tobinai, Yukio Kobayashi, Saburo Higuchi, Hiromu Kondo, Dai Maruyama, Shigeharu Yokohama, Lloyd J. Old, Herbert F. Oettgen, Michinori Ogura and Takumi Sugimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Takashi Watanabe

118 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Watanabe Japan 26 629 608 453 314 224 126 1.9k
Jingjing Wu China 33 1.6k 2.6× 675 1.1× 470 1.0× 407 1.3× 357 1.6× 146 3.4k
Eyal Fenig Israel 33 736 1.2× 1.3k 2.1× 260 0.6× 157 0.5× 108 0.5× 118 2.8k
Gary Elliott United States 19 493 0.8× 366 0.6× 599 1.3× 298 0.9× 221 1.0× 52 1.6k
Farhat L. Khanim United Kingdom 29 1.4k 2.3× 621 1.0× 307 0.7× 307 1.0× 88 0.4× 65 2.6k
Francesca Pentimalli Italy 38 2.3k 3.6× 1.1k 1.8× 280 0.6× 252 0.8× 146 0.7× 120 3.8k
R. Thompson United Kingdom 28 838 1.3× 640 1.1× 145 0.3× 843 2.7× 89 0.4× 75 3.1k
Antonella Naldini Italy 32 964 1.5× 389 0.6× 132 0.3× 584 1.9× 249 1.1× 97 2.7k
Jay S. Fine United States 34 978 1.6× 794 1.3× 166 0.4× 1.2k 3.8× 188 0.8× 79 3.4k
Laurent Gros France 24 1.1k 1.8× 418 0.7× 106 0.2× 564 1.8× 109 0.5× 59 2.3k
Yusuke Kobayashi Japan 31 1.3k 2.1× 532 0.9× 522 1.2× 525 1.7× 80 0.4× 232 3.4k

Countries citing papers authored by Takashi Watanabe

Since Specialization
Citations

This map shows the geographic impact of Takashi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Watanabe more than expected).

Fields of papers citing papers by Takashi Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Watanabe. The network helps show where Takashi Watanabe may publish in the future.

Co-authorship network of co-authors of Takashi Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Watanabe. A scholar is included among the top collaborators of Takashi Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Watanabe. Takashi Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Takanori, Eiji Munetsuna, Masahiro Mizuno, et al.. (2024). Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer. Scientific Reports. 14(1). 18494–18494. 1 indexed citations
2.
Inamura, Naoko, Takashi Watanabe, Hiromasa Aoki, et al.. (2024). Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease. Molecular Genetics and Metabolism. 142(3). 108497–108497. 1 indexed citations
3.
Watanabe, Takashi, Kazuhito Tsuboi, Yuta Ishizuka, et al.. (2023). Genetic ablation of Saposin‐D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination. Journal of Neurochemistry. 166(4). 720–746. 4 indexed citations
4.
Watanabe, Takashi, Akemi Suzuki, Shinji Go, et al.. (2022). The Urinary Bladder is Rich in Glycosphingolipids Composed of Phytoceramides. Journal of Lipid Research. 63(12). 100303–100303. 9 indexed citations
5.
Inamura, Naoko, Shinji Go, Takashi Watanabe, et al.. (2021). Reduction in miR‐219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease. Brain Pathology. 31(5). e12951–e12951. 8 indexed citations
6.
Watanabe, Takashi. (2020). GALC Expression in Macrophages Improves Peripheral Krabbe Disease. Trends in Glycoscience and Glycotechnology. 32(190). E213–E213.
7.
8.
Miyakawa, Yoshitaka, Hirokazu Kashiwagi, Toshiro Takafuta, et al.. (2014). [Consensus report for the management of pregnancy with primary immune thrombocytopenia].. PubMed. 55(8). 934–47. 6 indexed citations
9.
Watanabe, Takashi, et al.. (2013). New Fecal Biomarker, α1-acid Glycoprotein, for Evaluation of Inflammatory Bowel Disease : Comparison with Calprotectin and Lactoferrin. 40(3). 155–162. 2 indexed citations
10.
Nomoto, Junko, Nobuhiro Hiramoto, Motohiro Kato, et al.. (2012). Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma. BMC Cancer. 12(1). 457–457. 31 indexed citations
11.
Maeshima, Akiko Miyagi, Hirokazu Taniguchi, Suguru Fukuhara, et al.. (2012). Bcl‐2, Bcl‐6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy. Cancer Science. 103(10). 1898–1904. 14 indexed citations
12.
Watanabe, Takashi, Kensei Tobinai, Taro Shibata, et al.. (2011). Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial. Journal of Clinical Oncology. 29(30). 3990–3998. 45 indexed citations
13.
Tamura, Daisuke, Tokuzo Arao, Kaoru Tanaka, et al.. (2010). Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition. Cancer Science. 101(6). 1403–1408. 48 indexed citations
14.
Tobinai, Kensei, Michinori Ogura, Yukio Kobayashi, et al.. (2010). Phase I study of LY2469298, an Fc‐engineered humanized anti‐CD20 antibody, in patients with relapsed or refractory follicular lymphoma. Cancer Science. 102(2). 432–438. 25 indexed citations
15.
Watanabe, Takashi, et al.. (2008). A CASE WITH COLLAGENOUS COLITIS AND MULTIPLE LONGITUDINAL ULCERS. Acta gastro-enterologica belgica. 50(1). 27–33. 3 indexed citations
16.
Kondo, Hiromu, Yutaka Takahashi, Takashi Watanabe, Shigeharu Yokohama, & Jun Watanabe. (2003). Gastrointestinal transit of liquids in unfed cynomolgus monkeys. Biopharmaceutics & Drug Disposition. 24(3). 131–140. 16 indexed citations
17.
Takahashi, Yutaka, et al.. (2002). Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs. International Journal of Pharmaceutics. 246(1-2). 85–94. 73 indexed citations
18.
Sakamoto, Noriho, Takashi Watanabe, Takashi Harada, et al.. (2001). A case of traumatic venous pseudoaneurysm.. Nihon Toseki Igakkai Zasshi. 34(8). 1197–1199.
19.
Teramura, Toshio, Takashi Tokunaga, Hitoshi Matsumoto, Takashi Watanabe, & S. Higuchi. (1996). Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog. Xenobiotica. 26(2). 177–187. 3 indexed citations
20.
Watanabe, Takashi, Hiromitsu Nakauchi, Kazumasa Matsuki, et al.. (1985). T-Cell Subsets in Patients with Gastric Cancer. Oncology. 42(2). 89–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Wu Breakdown of academic impact, for papers by Eyal Fenig Breakdown of academic impact, for papers by Gary Elliott Breakdown of academic impact, for papers by Farhat L. Khanim Breakdown of academic impact, for papers by Francesca Pentimalli Breakdown of academic impact, for papers by R. Thompson Breakdown of academic impact, for papers by Antonella Naldini Breakdown of academic impact, for papers by Jay S. Fine Breakdown of academic impact, for papers by Laurent Gros Breakdown of academic impact, for papers by Yusuke Kobayashi
Rankless by CCL
2026